GeneralConnection.com ➔ Dictionary
Dictionary Search

myotonic

Synonyms

Adjective

1. tonicity

2. tonus, tone

Usage
Dialing Back Stiffness May Protect Muscles in Myotonic Dystrophy - University of Rochester
Myotonic Dystrophy Foundation Chair Jeremy Kelly Awarded OBE by King Charles III - EIN Presswire
An Antibody–Oligonucleotide Conjugate for Myotonic Dystrophy Type 1 - The New England Journal of Medicine
Aberrantly spliced α-dystrobrevin alters α-syntrophin binding in myotonic dystrophy type 1 - Neurology® Journals
Targeted long-read sequencing for high-resolution repeat profiling in myotonic dystrophy type 1 - Nature
Source of gastrointestinal problems in myotonic dystrophy - National Institutes of Health (NIH) | (.gov)
MDA 2026: Dyne therapy boosts strength, cognition in DM1 - Muscular Dystrophy News
Undiagnosed Maternal Myotonic Dystrophy Type 1 Revealed by Congenital Myotonic Dystrophy in the Neonate - Cureus
Muscle disease - Myotonic, Dystrophy, Congenital - Encyclopedia Britannica
MBNL loss of function in smooth muscle as a model for myotonic dystrophy associated gastrointestinal dysmotility - PNAS
ARTHEx Biotech Delivers Multiple Presentations at IDMC-15 Highlighting Clinical Progress of ATX-01 and Mechanistic Insights for Myotonic Dystrophy Type 1 (DM1) and 2 (DM2) - PR Newswire
Therapeutic Promise and Mechanism of DYNE-101 to Treat Myotonic Dystrophy: Doug Kerr, MD, PhD - NeurologyLive
Sarepta Provides Progress Update for SRP-1003, its Investigational siRNA treatment for Myotonic Dystrophy Type 1 - Sarepta Therapeutics
Reducing Muscle Stiffness Could Help Myotonic Dystrophy Patients - Bioengineer.org
Toward Trial Readiness in Congenital Myotonic Dystrophy - Neurology® Journals
Myotonic dystrophy type 1: clinical diversity, molecular insights and therapeutic perspectives - Nature
Characterizing white matter hyperintensities in myotonic dystrophy type 1 through IVIM derived metrics - Nature
Neonatal congenital myotonic dystrophy with DMPK gene expansion: clinical features and short-term outcomes - Frontiers
Role of Otolaryngology in Monitoring the Progression of Myotonic Dystrophy: A Case Report - Cureus
Myotonic dystrophy drug SRP-1003 trial advances to higher doses - Muscular Dystrophy News
AMO Pharma Announces Update on Scientific Advice for Registrational Clinical Study of AMO-02 in Congenital Myotonic Dystrophy Type 1 Following Meetings with the U.S. Food and Drug Administration, the U.K. Medicines and Healthcare products Regulator - PR Newswire
PepGen Announces Presentations at the 15th International Myotonic Dystrophy Consortium Highlighting Clinical Data from the PGN-EDODM1 Program - Business Wire
Pre- and postsynaptic upregulation of FasII synergistically underlies neuropathological and behavioral phenotypes in a Drosophila model of myotonic dystrophy - Nature
Safety and efficacy of novel antibody-oligonucleotide therapy for myotonic dystrophy type 1 - 2 Minute Medicine
2026 Grad Slam winner strives to understand sleep disruptions in myotonic dystrophy - Newsroom | UCLA
Breakthrough in RNA Research Could Lead to Treatment for Neuromuscular Disorders - Carnegie Mellon University
Antibody-Oligonucleotide Conjugate Shows Promise in Myotonic Dystrophy Type 1 - MedPage Today
PepGen’s Mid-Stage Myotonic Dystrophy Study Hit With ‘Surprise’ Pause - BioSpace
An antibody-siRNA conjugate could treat myotonic dystrophy - BioXconomy
ARTHEx Biotech Granted FDA Fast Track Designation for ATX-01 for the Treatment of Myotonic Dystrophy Type 1 (DM1) - PR Newswire
Dyne hopes to bring new treatment for DM1 to US market in 2028 - Muscular Dystrophy News
Over-contracted gut muscles drive gastrointestinal symptoms in myotonic dystrophy - News-Medical
Miles of Hope: A year-long ride for Myotonic Dystrophy awareness - News 9
AMO-02 for myotonic dystrophy type 1 - Muscular Dystrophy News
Discovery and characterization of Arthex Biotech’s ATX-01 for myotonic dystrophy type 1 - BioWorld News
FDA Grants Fast Track Designation to SAR446268 Gene Therapy for Non-Congenital Myotonic Dystrophy Type 1 - Vera Health
MDA 2026: Early trial of PGN-EDODM1 shows biomarker activity in DM1 - Muscular Dystrophy News
Gene Therapy Fast Tracked for Non-Congenital Myotonic Dystrophy Type 1 - Neurology Advisor
Myotonia Drug Gets Green Light for Pediatric Patients in EU - Medscape
Whitehall man rides 200K miles to raise money, awareness for myotonic muscular dystrophy - WFMZ.com
PepGen muscular dystrophy drug gets ‘surprise’ hold from FDA - BioPharma Dive
Dyne Therapeutics Announces Completion of Enrollment in Registrational Expansion Cohort of ACHIEVE Trial of Z-Basivarsen for Myotonic Dystrophy Type 1 (DM1) - Yahoo Finance
New ‘pothole-filling’ RNA strategy targets the genetic root of DM1 - Muscular Dystrophy News
Del-desiran for myotonic dystrophy type 1 - Muscular Dystrophy News
DM1 gene therapy trial seeks patients ages 10-50 - Muscular Dystrophy News
Sarepta Announces First Clinical Data from siRNA Pipeline Targeting FSHD1 and DM1 - Sarepta Therapeutics
Man stops in Tampa before finishing 200k miles on motorcycle for rare disease - Spectrum Bay News 9
AMO Pharma Announces Update on Scientific Advice for Registrational Clinical Study of AMO-02 in Congenital Myotonic Dystrophy Type 1 Following Meetings with the U.S. Food and Drug Administration, the U.K. Medicines and Healthcare products Regulator - Yahoo! Finance Canada
The New England Journal of Medicine Publishes Results from Phase 1/2 MARINA® Trial of Delpacibart Etedesiran (del-desiran) for Treatment of Myotonic Dystrophy Type 1 - BioSpace
PepGen Loses Half of Share Price on Mixed Data in Rare Muscle-Wasting Disease - BioSpace
Development and Validation of a Disease-Specific, Patient-Reported Outcome Measure: The Myotonic Dystrophy Type 2 Health Index - Wiley Online Library
Alternative Splicing of SORBS1 Affects Neuromuscular Junction Integrity in Myotonic Dystrophy Type 1 - Wiley Online Library
Dyne commences Phase III HARMONIA trial for DM1 therapy - Clinical Trials Arena
AMO Pharma Reports Long-Term Safety Data from REACHCDM-X Study of AMO-02 in Treatment of Congenital Myotonic Dystrophy Type 1 - PR Newswire
Myotonic Dystrophy Foundation Expanding Global Treatment - BORGEN Magazine
Structure-based RNA could lead to treatment for neuromuscular disorders - Medical Xpress
Landmarks light up green for Myotonic Dystrophy Awareness Day - WRGB
Dyne Therapeutics Receives Orphan Drug Designation in Japan for Zeleciment Basivarsen (DYNE-101) for Myotonic Dystrophy Type 1 - Yahoo Finance
Design Therapeutics begins DM1 trial for DT-818, aims at genetic cause - Stock Titan
Overviewing Positive Early Data from ACHIEVE Trial of Zeleciment Basivarsen in DM1: Doug Kerr, MD, PhD - NeurologyLive
AMO Pharma Announces Update on Scientific Advice for Registrational Clinical Study of AMO-02 in Congenital Myotonic Dystrophy Type 1 Following Meetings with the U.S. Food and Drug Administration, the U.K. Medicines and Healthcare products Regulator - The Journal Gazette
PepGen hit with partial clinical hold, analyst blames 'understaffed FDA' - Fierce Biotech
AMO Pharma Announces Update on Scientific Advice for Registrational Clinical Study of AMO-02 in Congenital Myotonic Dystrophy Type 1 Following Meetings with the U.S. Food and Drug Administration, the U.K. Medicines and Healthcare products Regulator - MyHorryNews.com
Experimental DM1 drug hits key trial milestone, Dyne eyes 2028 US launch - Stock Titan
AMO Pharma Announces Update on Scientific Advice for Registrational Clinical Study of AMO-02 in Congenital Myotonic Dystrophy Type 1 Following Meetings with the U.S. Food and Drug Administration, the U.K. Medicines and Healthcare products Regulator - Colchester Sun
Sarepta CEO Doug Ingram To Step Down as Muscular Dystrophy Mission Hits Home - BioSpace
PepGen Reports First Quarter 2026 Financial Results and Recent Corporate Highlights - BioSpace
Muscular Dystrophy Association Announces More Than $2.7 Million For Research Grants to Advance Breakthroughs Across Neuromuscular Diseases - Muscular Dystrophy Association
AMO Pharma Announces Update on Scientific Advice for Registrational Clinical Study of AMO-02 in Congenital Myotonic Dystrophy Type 1 Following Meetings with the U.S. Food and Drug Administration, the U.K. Medicines and Healthcare products Regulator - The Berkshire Eagle
Researchers provide answers to progressive heart problems in muscular dystrophy and potential reversibility - Baylor College of Medicine Blog Network -
Mouse model reveals unsuspected effects of muscular dystrophy in the GI - Baylor College of Medicine Blog Network -
CUHK scientists reveal a new mechanism by which myotonic dystrophy type 1 damages the nervous system - CUHK Communications and Public Relations Office
Three cases of pregnancies complicated with myotonic dystrophy type 1 - obgyn.onlinelibrary.wiley.com
ARTHEx Biotech Upsizes Series B Financing Round to $87M to Advance Lead Program ATX-01 in Myotonic Dystrophy Type 1 and Expand Pipeline of Targeted RNA Medicines - PR Newswire
Fight, Flight, Or Fall Over: Meet The Myotonic Goat - IFLScience
News - New research could unlock ways to treat myotonic dystrophy - University of Nottingham
Dyne Therapeutics Initiates Phase 3 HARMONIA Trial to Evaluate Efficacy of Z-Basivarsen in Myotonic Dystrophy Type 1 - Quiver Quantitative
AMO Pharma Announces Update on Scientific Advice for Registrational Clinical Study of AMO-02 in Congenital Myotonic Dystrophy Type 1 Following Meetings with the U.S. Food and Drug Administration, the U.K. Medicines and Healthcare products Regulator - nny360.com
Sarepta shares positive safety update on DM1 asset as Arrowhead snares $200M milestone - Fierce Biotech
FDA curtails Pepgen’s Freedom2 operate in DM1 - BioWorld News
'Vroom Old Man' surpasses fundraising, distance goals in motorcycle ride for disease research - KCENTV.com
'Vroom Old Man' | One man's 200,000-mile motorcycle mission to fight rare disease - KCENTV.com
Chronic endoplasmic reticulum stress in myotonic dystrophy type 2 promotes autoimmunity via mitochondrial DNA release - Nature
Pearls & Oy-sters: Severe Myotonic Crisis Resembling Malignant Hyperthermia - Neurology® Journals
Real-World Study Provides Support for Lamotrigine in Treating Non-Dystrophic Myotonias - NeurologyLive
Autism-related traits in myotonic dystrophy type 1 model mice are due to MBNL sequestration and RNA mis-splicing of autism-risk genes - Nature
Dyne Therapeutics Reports Significant One-Year Clinical Data for Zeleciment Basivarsen in Patients with Myotonic Dystrophy Type 1 - Quiver Quantitative
MDA 2024: Myotonic dystrophy type 1 reverses with AOC 1001 treatment - Muscular Dystrophy News
PepGen’s stock up 120% on DM1 trial success - Clinical Trials Arena
Clearance of defective muscle stem cells by senolytics restores myogenesis in myotonic dystrophy type 1 - Nature
ARTHEx Biotech: Series B Round Upsized To $87 Million For Myotonic Dystrophy Treatment Development - Pulse 2.0
Analysis of human urinary extracellular vesicles reveals disordered renal metabolism in myotonic dystrophy type 1 - Nature
[8-K] PepGen Inc. Reports Material Event - Stock Titan
FORCE platform overcomes barriers of oligonucleotide delivery to muscle and corrects myotonic dystrophy features in preclinical models | Communications Medicine - Nature
Calcium Channel Blockers Key to Reversing Myotonic Dystrophy Muscle Weakness, Study Finds - University of Rochester
Use of HSALR female mice as a model for the study of myotonic dystrophy type I | Lab Animal - Nature
Altered drug metabolism and increased susceptibility to fatty liver disease in a mouse model of myotonic dystrophy - Nature
Myotonic dystrophy RNA toxicity alters morphology, adhesion and migration of mouse and human astrocytes - Nature
Myotonic Dystrophy Type 2 Caused by a CCTG Expansion in Intron 1 of ZNF9 - Science | AAAS
Myotonic dystrophy: GABA receptors implicated in sleepiness, via mouse model - Emory News
Foreign Language Equivalents
Foreign Language Equivalents of 'myotonic'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
muotonic,   myotonix,   mmyotonic,   ymotonic,   myptonic,   myotinic,   myoronic,   myootonic,   myotonicc,   mtotonic,   myotoni,   myyotonic,   myootnic,   myotoinc,   myotonuc,   myotoniic,   myotoniv,   myitonic,   mytoonic,   myotpnic,   moytonic,   myoonic,   myotonc,   myotonnic,   myotonci,   yotonic,   nyotonic,   myotonoc,   myotobic,   myotnoic,   myottonic,   mytonic,   ,yotonic,   myotoonic,   myotnic,   myotoic,   motonic,   myotomic,   myoyonic
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z